Response to: The use of low-dose quetiapine does not necessarily increase the risk of major adverse cardiovascular events

Acta Neuropsychiatr. 2023 Feb;35(1):3-4. doi: 10.1017/neu.2023.3. Epub 2023 Jan 5.

Mikkel Højlund^{1

2}, Kjeld Andersen^{3

4}, Martin T Ernst¹, Christoph U Correll^{5

6

7}, Jesper Hallas¹

¹ Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
² Department of Psychiatry Aabenraa, Mental Health Services in the Region of Southern Denmark, Aabenraa, Denmark.
³ Department of Clinical Research, Psychiatry, University of Southern Denmark, Odense, Denmark.
⁴ Department of Psychiatry Odense, Mental Health Services in the Region of Southern Denmark, Odense, Denmark.
⁵ Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, NY, USA.
⁶ Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
⁷ Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany.

No abstract available

Publication types